$125 | Single User
$250 | Site License
$375 | Global License

Northwest Biotherapeutics Inc (NWBO) - Financial and Strategic SWOT Analysis Review
[Published by Global Data]

Published by Global Data: 16 Aug 2019 | 234770 | In Stock
Related Topics: Biotherapeutics

Introduction

Northwest Biotherapeutics Inc (NWBO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.

- Corporate strategy – Analyst’s summarization of the company’s business strategy.

- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.

- Company history – Progression of key events associated with the company.

- Major products and services – A list of major products, services and brands of the company.

- Key competitors – A list of key competitors to the company.

- Key employees – A list of the key executives of the company.

- Executive biographies – A brief summary of the executives’ employment history.

- Key operational heads – A list of personnel heading key departments/functions.

- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.

- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Northwest Biotherapeutics Inc (NW Bio) is a development stage biotechnology company. It discovers and develops immunotherapy products to treat cancer. The company uses its proprietary technology platform, DCVax to develop therapeutic product candidates. DCVax is a personalized immune therapy and consists of therapeutic vaccine which uses patient’s own dendritic cells as the therapeutic agent. NW Bio’s product lines include DCVax-L, for the treatment of glioblastoma multiforme (GBM), brain cancer and metastatic ovarian cancer; DCVax-Direct, for the treatment of all inoperable solid tumor cancers; and DCVax-Prostate, for the treatment of late stage prostate cancer. NW Bio is headquartered in Bethesda, Maryland, the US.

Northwest Biotherapeutics Inc Key Recent Developments

May 28,2019: NW Bio announces settlement with Cognate Bioservices resolving past matters and providing for restart of DCVax-Direct production

Feb 26,2019: NW Bio Hires David Innes As Vice President, Investor Relations

Dec 14,2018: NW Bio announces that UK Property transaction has closed, including funding of approximately .3 million gross proceeds

Aug 29,2018: NW Bio announces upcoming presentation by Dr. Marnix Bosch at immuno-oncology summit

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents
for Northwest Biotherapeutics Inc (NWBO) - Financial and Strategic SWOT Analysis Review [Published by Global Data]

  • Table of Contents

    Table of Contents

    List of Tables

    List of Figures

    Section 1 - About the Company

    Northwest Biotherapeutics Inc - Key Facts

    Northwest Biotherapeutics Inc - Key Employees

    Northwest Biotherapeutics Inc - Key Employee Biographies

    Northwest Biotherapeutics Inc - Major Products and Services

    Northwest Biotherapeutics Inc - History

    Northwest Biotherapeutics Inc - Locations And Subsidiaries

    Head Office

    Other Locations & Subsidiaries

    Section 2 – Company Analysis

    Company Overview

    Northwest Biotherapeutics Inc - Business Description

    Northwest Biotherapeutics Inc - SWOT Analysis

    SWOT Analysis - Overview

    Northwest Biotherapeutics Inc - Strengths

    Northwest Biotherapeutics Inc - Weaknesses

    Northwest Biotherapeutics Inc - Opportunities

    Northwest Biotherapeutics Inc - Threats

    Northwest Biotherapeutics Inc - Key Competitors

    Section 3 – Company Financial Ratios

    Financial Ratios - Capital Market Ratios

    Financial Ratios - Annual Ratios

    Performance Chart

    Financial Performance

    Financial Ratios - Interim Ratios

    Financial Ratios - Ratio Charts

    Section 4 – Company’s Lifesciences Financial Deals and Alliances

    Northwest Biotherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

    Northwest Biotherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

    Northwest Biotherapeutics Inc, Recent Deals Summary

    Section 5 – Company’s Recent Developments

    May 28, 2019: NW Bio announces settlement with Cognate Bioservices resolving past matters and providing for restart of DCVax-Direct production

    Feb 26, 2019: NW Bio Hires David Innes As Vice President, Investor Relations

    Dec 14, 2018: NW Bio announces that UK Property transaction has closed, including funding of approximately .3 million gross proceeds

    Aug 29, 2018: NW Bio announces upcoming presentation by Dr. Marnix Bosch at immuno-oncology summit

    Section 6 – Appendix

    Methodology

    Ratio Definitions

    About GlobalData

    Contact Us

    Disclaimer

List Of Tables
in Northwest Biotherapeutics Inc (NWBO) - Financial and Strategic SWOT Analysis Review [Published by Global Data]

List of Tables

Northwest Biotherapeutics Inc, Key Facts

Northwest Biotherapeutics Inc, Key Employees

Northwest Biotherapeutics Inc, Key Employee Biographies

Northwest Biotherapeutics Inc, Major Products and Services

Northwest Biotherapeutics Inc, History

Northwest Biotherapeutics Inc, Subsidiaries

Northwest Biotherapeutics Inc, Key Competitors

Northwest Biotherapeutics Inc, Ratios based on current share price

Northwest Biotherapeutics Inc, Annual Ratios

Northwest Biotherapeutics Inc, Annual Ratios (Cont...1)

Northwest Biotherapeutics Inc, Interim Ratios

Northwest Biotherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Northwest Biotherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Northwest Biotherapeutics Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List Of Figures, Charts and Diagrams
in Northwest Biotherapeutics Inc (NWBO) - Financial and Strategic SWOT Analysis Review [Published by Global Data]

List of Figures

Northwest Biotherapeutics Inc, Performance Chart (2014 - 2018)

Northwest Biotherapeutics Inc, Ratio Charts

Northwest Biotherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Northwest Biotherapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

Additional Details

Publisher

Global Data

Publisher Information

Reference

234770 |

Number of Pages

36

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Northwest Biotherapeutics Inc (NWBO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryNorthwest Biotherapeutics Inc (NW Bio) is a development stage biotechnology company. It disco...
09 Nov 2018 by Global Data USD $250 More Info
Northwest Biotherapeutics Inc (NWBO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryNorthwest Biotherapeutics Inc (NW Bio) is a development stage biotechnology company. It disco...
25 Nov 2016 by Global Data USD $250 More Info
Northwest Biotherapeutics, Inc. (NWBO) - Medical Equipment - Deals and Alliances Profile
SummaryNorthwest Biotherapeutics Inc (NW Bio) is a development stage biotechnology company. It disco...
14 Nov 2016 by Global Data USD $250 More Info
Northwest Biotherapeutics, Inc. (NWBO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryNorthwest Biotherapeutics, Inc. (NW Bio) is a development stage biotechnology company. It dis...
24 Aug 2016 by Global Data USD $250 More Info
Northwest Biotherapeutics, Inc. (NWBO) - Medical Equipment - Deals and Alliances Profile
SummaryNorthwest Biotherapeutics, Inc. (NW Bio) is a development stage biotechnology company. It dis...
21 Jul 2016 by Global Data USD $250 More Info
Northwest Biotherapeutics, Inc. (NWBO) - Financial and Strategic SWOT Analysis Review
Northwest Biotherapeutics, Inc. (NWBO) - Financial and Strategic SWOT Analysis Review provides you a...
03 May 2016 by Global Data USD $125 More Info
Northwest Biotherapeutics, Inc. (NWBO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryNorthwest Biotherapeutics, Inc. (NW Bio) is a development stage biotechnology company. It dis...
15 Apr 2016 by Global Data USD $250 More Info
Northwest Biotherapeutics, Inc. (NWBO) - Medical Equipment - Deals and Alliances Profile
SummaryNorthwest Biotherapeutics, Inc. (NW Bio) is a development stage biotechnology company. It dis...
14 Apr 2016 by Global Data USD $250 More Info
Northwest Biotherapeutics, Inc. (NWBO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryNorthwest Biotherapeutics, Inc. (NW Bio) is a development stage biotechnology company. It dis...
08 Mar 2016 by Global Data USD $250 More Info
Northwest Biotherapeutics, Inc. (NWBO) - Medical Equipment - Deals and Alliances Profile
SummaryNorthwest Biotherapeutics, Inc. (NW Bio) is a development stage biotechnology company. It dis...
24 Feb 2016 by Global Data USD $250 More Info

This report is published by Global Data

Download Free Report Summary PDF

Northwest Biotherapeutics Inc (NWBO) - Financial and Strategic SWOT Analysis Review [Published by Global Data] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...